Correlation Between Sinil Pharmaceutical and Korean Reinsurance

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sinil Pharmaceutical and Korean Reinsurance at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sinil Pharmaceutical and Korean Reinsurance into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sinil Pharmaceutical Co and Korean Reinsurance Co, you can compare the effects of market volatilities on Sinil Pharmaceutical and Korean Reinsurance and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sinil Pharmaceutical with a short position of Korean Reinsurance. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sinil Pharmaceutical and Korean Reinsurance.

Diversification Opportunities for Sinil Pharmaceutical and Korean Reinsurance

-0.65
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Sinil and Korean is -0.65. Overlapping area represents the amount of risk that can be diversified away by holding Sinil Pharmaceutical Co and Korean Reinsurance Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Korean Reinsurance and Sinil Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sinil Pharmaceutical Co are associated (or correlated) with Korean Reinsurance. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Korean Reinsurance has no effect on the direction of Sinil Pharmaceutical i.e., Sinil Pharmaceutical and Korean Reinsurance go up and down completely randomly.

Pair Corralation between Sinil Pharmaceutical and Korean Reinsurance

Assuming the 90 days trading horizon Sinil Pharmaceutical Co is expected to under-perform the Korean Reinsurance. But the stock apears to be less risky and, when comparing its historical volatility, Sinil Pharmaceutical Co is 1.08 times less risky than Korean Reinsurance. The stock trades about -0.29 of its potential returns per unit of risk. The Korean Reinsurance Co is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  794,000  in Korean Reinsurance Co on September 12, 2024 and sell it today you would earn a total of  5,000  from holding Korean Reinsurance Co or generate 0.63% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Sinil Pharmaceutical Co  vs.  Korean Reinsurance Co

 Performance 
       Timeline  
Sinil Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sinil Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Korean Reinsurance 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Korean Reinsurance Co are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Korean Reinsurance sustained solid returns over the last few months and may actually be approaching a breakup point.

Sinil Pharmaceutical and Korean Reinsurance Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sinil Pharmaceutical and Korean Reinsurance

The main advantage of trading using opposite Sinil Pharmaceutical and Korean Reinsurance positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sinil Pharmaceutical position performs unexpectedly, Korean Reinsurance can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Korean Reinsurance will offset losses from the drop in Korean Reinsurance's long position.
The idea behind Sinil Pharmaceutical Co and Korean Reinsurance Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Other Complementary Tools

Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Fundamental Analysis
View fundamental data based on most recent published financial statements
CEOs Directory
Screen CEOs from public companies around the world
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm